Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
90,162,238
-
Total 13F shares
-
30,825,168
-
Share change
-
+1,967,164
-
Total reported value
-
$770,865,500
-
Put/Call ratio
-
125%
-
Price per share
-
$25.01
-
Number of holders
-
55
-
Value change
-
+$50,186,925
-
Number of buys
-
30
-
Number of sells
-
25
Institutional Holders of Centessa Pharmaceuticals plc - COMMON STOCK (CNTA) as of Q4 2025
As of 31 Dec 2025,
Centessa Pharmaceuticals plc - COMMON STOCK (CNTA) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,825,168 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, FRANKLIN RESOURCES INC, FEDERATED HERMES, INC., Capital World Investors, GOLDMAN SACHS GROUP INC, BlackRock, Inc., UBS Group AG, JANE STREET GROUP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and TD Asset Management Inc.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.